Success with dostarlimab immunotherapy for uterine cancer with mismatch repair mutations

zsazsa1

https://www.nytimes.com/2025/04/27/health/cancer-immunotherapy-solid-tumors.html?unlocked_article_code=1.C08.fnfM.3jbPvxka1eGQ&smid=url-share

Free link to NYT article. It is showing excellent results in other solid tumors, too. It's approved for uterine cancer with mismatch repair mutations, and in trial for certain other tumors.

NoTimeForCancer

Thank you, zsazsa